Connect with us

Hi, what are you looking for?

Entertainment

Brandon Beemer returns to ‘Days of Our Lives’ on NBC this summer

In the daytime drama Days of Our Lives, Beemer played the role of Shawn-Douglas Brady from 2006 to 2008, and then again, since 2016 on a recurring basis.

“Good to be back for a bit. Great promo,” Beemer exclaimed via a post on Twitter. This summer, according to that promo, Days of Our Lives is expected to be filled with “plenty of surprises.”

This year, Beemer earned his second career Daytime Emmy nomination for “Outstanding Supporting Actor in a Digital Drama Series” for his portrayal of Evan Blackwell in the multi Emmy-award-winning digital drama series The Bay on Amazon Prime.

Fans and viewers can binge The Bay on Amazon Prime by clicking here.

To learn more about actor Brandon Beemer, follow him on Twitter and on Instagram.

Read More: In April of 2019, Brandon Beemer chatted with Digital Journal about his acting career and the impact of technology on the entertainment industry.

Markos Papadatos
Written By

Markos Papadatos is Digital Journal's Editor-at-Large for Music News. Papadatos is a Greek-American journalist and educator that has authored over 21,000 original articles over the past 18 years. He has interviewed some of the biggest names in music, entertainment, lifestyle, magic, and sports. He is a 16-time "Best of Long Island" winner, where for three consecutive years (2020, 2021, and 2022), he was honored as the "Best Long Island Personality" in Arts & Entertainment, an honor that has gone to Billy Joel six times.

You may also like:

Entertainment

Liam Hemsworth as Owen Brophy in 'Lonely Planet.' Photo Credit: Hilary Bronwyn Gayle, Netflix.Australian actor Liam Hemsworth stars in the new movie “Lonely Planet”...

Business

The European Central Bank is expected to lower interest rates again this week.

Business

Many professionals do not realise that just by working in certain industries, their personal data—emails, passwords, financial details—can be compromised.

Life

The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache.